“Value-focused special situations fund delivered 38.54% returns in 2023 through concentrated positions in broken biotechs undergoing strategic alternatives, regional banks trading below book value, and commercial real estate opportunities. Portfolio benefits from...”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.